Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-31

Clinical Trial Update: Antihypertensive Effect and Safety of Peptides Derived From Coldwater Shrimp [Phase 2]

View source ↗

Summary

A Phase 2 study assessing the antihypertensive effect and safety of peptides derived from coldwater shrimp in people with hypertension. The trial status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Shrimp-derived antihypertensive peptides (peptides derived from coldwater shrimp)

Snippet

Sponsor: Marealis AS | Conditions: Hypertension, Blood Pressure | Phase 2 | Status: COMPLETED